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background: Most patients hospitalized for heart failure (HF) have dyspnea, yet the associations between dyspnea severity, outcomes, and health 
care costs are unknown.
methods: We linked data from the ADHERE registry for 2001 through 2006 with Medicare claims to identify patients ≥65 years who were 
hospitalized for HF. We classified patients into 3 groups based on dyspnea severity at admission: dyspnea on moderate exertion (mild dyspnea), 
dyspnea on minimal exertion (moderate dyspnea), or dyspnea at rest (severe dyspnea). Outcomes of interest were mortality at 30 days post-
admission, length of stay (LOS), and 30-day post-discharge endpoints: days alive and out of the hospital (DAOH), rehospitalization (HF and all-
cause), and Medicare payments.
results: Of 48,616 patients, 4,022 (8.3%) had mild dyspnea, 19,619 (40.3%) had moderate dyspnea and 24,975 (51.4%) had severe dyspnea. 
Patients with severe dyspnea had the highest rates of mortality and rehospitalization. After multivariable adjustment, severe dyspnea was 
independently associated with increased 30-day mortality, fewer DAOH, longer LOS and higher Medicare payments compared to moderate dyspnea 
(Table).
conclusion: Severe dyspnea on admission for HF was associated with increased LOS, mortality, and health care costs. Severe dyspnea on 
admission for HF should be recognized as an independent predictor of outcomes and costs.
